Journal profile · Otorhinolaryngology
Otology & Neurotology
ISSN 1531-7129 · eISSN 1537-4505 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 2001
Otology & Neurotology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 1.7; JCR Q2 (journal website); hybrid open access; median 140 days to acceptance (95 articles, last 24 months); community-reported acceptance: easy; 396 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Otology & Neurotology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ear Surgery and Otitis Media, Hearing, Cochlea, Tinnitus, Genetics and Hearing Loss and Rehabilitation, together about 50.1% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
To investigate whether there is a difference between electrode frequencies estimated in OTOPLAN according to anatomy using a preoperative CT scan and electrode frequencies based on postoperative cone beam computer tomography (CBCT).
From the journal's Aims & Scope
Research area (LetPub): Otorhinolaryngology
Editor-in-chief Matthew L. BushPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ear Surgery and Otitis MediaMedicine19.8%
- Hearing, Cochlea, Tinnitus, GeneticsNeuroscience16.7%
- Hearing Loss and RehabilitationNeuroscience13.7%
- Vestibular and auditory disordersNeuroscience12.6%
- Meningioma and schwannoma managementMedicine6.1%
- Facial Nerve Paralysis Treatment and ResearchMedicine6%
- Ear and Head TumorsMedicine3.7%
- Reconstructive Facial Surgery TechniquesMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Otorhinolaryngology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Otorhinolaryngology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Otorhinolaryngology | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · CLINICAL NEUROLOGY · rank 219/296
- JCR Q2 · OTORHINOLARYNGOLOGY · rank 27/67
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.7LetPub ·
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 3.1LetPub ·
- SJR 2026-06
- 0.79LetPub ·
- SNIP 2026-06
- 1.02LetPub ·
- h-index
- 93LetPub ·
- h-index
- 143OpenAlex ·
- i10-index
- 4,570OpenAlex ·
- 2-year mean citedness
- 1.66OpenAlex ·
- Self-citation rate
- 11.8%LetPub ·
- Share of gold OA articles
- 10.47%LetPub ·
Volume
- Articles per year
- 265LetPub ·
Articles by year OpenAlex count · 8,806 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 270 | 47 | 36 |
| 2025 | 396 | 79 | 516 |
| 2024 | 319 | 75 | 1,086 |
| 2023 | 286 | 78 | 1,617 |
| 2022 | 351 | 91 | 2,755 |
| 2021 | 421 | 99 | 4,290 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
140 daysMedian, submission to acceptance · P25–P75 102 days – 209 days
- Acceptance to online
- median 47 days (91 articles)
- Submission to online
- median 203 days
- Sample
- 95 articles with submission and acceptance dates (747 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2001
- ISSN
- 1531-7129
- Electronic ISSN
- 1537-4505
- Latest issue on the website
- Volume 47, Issue 9 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Otology & Neurotology
What CAS zone is Otology & Neurotology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Otology & Neurotology is in Zone 3 of Medicine, and in Zone 3 of the minor category Clinical Neurology / Otorhinolaryngology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Otology & Neurotology?
The latest impact factor listed by LetPub is 1.7; CiteScore 3.1, h-index 143.
How long does peer review take at Otology & Neurotology?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 140 days (interquartile range 102–209 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Otology & Neurotology in?
The journal's website gives JCR Q2; by category, CLINICAL NEUROLOGY Q3 (219/296), OTORHINOLARYNGOLOGY Q2 (27/67). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index Otology & Neurotology?
According to LetPub and DOAJ records, Otology & Neurotology is indexed in SCIE and Scopus.
Is Otology & Neurotology open access, and what is the APC?
Otology & Neurotology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .